Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +1,000 $15.00 $15K 1,000
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +1,000 $15.00 $15K 1,000
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +1,000 $15.00 $15K 1,000
2019-10-07 SCHADE CHRISTIAN S President & CEO Purchase +5,000 $15.00 $75K 5,000
2019-10-07 SCHADE CHRISTIAN S President & CEO Grant or award · Stock Option (right to Buy) +306,085 306,085
2019-10-07 KDev Investments AB 10% owner Conversion +1,600,559 2,444,837
2019-10-07 KDev Investments AB 10% owner Conversion · Series A Convertible Preferred Stock −579,647 0
2019-10-07 KDev Investments AB 10% owner Conversion · Series B Convertible Preferred Stock −590,445 0
2019-10-07 KDev Investments AB 10% owner Conversion · Series C Convertible Preferred Stock −430,467 0
2019-10-07 HealthCap VII, L.P. 10% owner Conversion +1,661,382 1,671,941
2019-10-07 HealthCap VII, L.P. 10% owner Conversion +427,496 2,099,437
2019-10-07 HealthCap VII, L.P. 10% owner Purchase +266,667 $15.00 $4.0M 2,366,104
2019-10-07 HealthCap VII, L.P. 10% owner Conversion · Series B Convertible Preferred Stock −1,661,382 0
2019-10-07 HealthCap VII, L.P. 10% owner Conversion · Series C Convertible Preferred Stock −427,496 0

Page 17 of 17 · 334 trades